Santen Pharmaceutical Co (SNPHF) Receives a Buy from Goldman Sachs
Goldman Sachs analyst maintained a Buy rating on Santen Pharmaceutical Co today and set a price target of Yen2,200.00. The company’s shares closed last Wednesday at $11.45.Elevate Your Investing Strategy:...